Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
IJH vs XBI: how they differ
IJH and XBI hold 3% of their weight in the same names, and XBI returned more over the year.
iShares Core S&P Mid-Cap ETF and State Street(R) SPDR(R) S&P(R) Biotech ETF.
What they hold in common
By the books each fund has filed, IJH and XBI hold 3% of their money in the same securities at the same weight.
| Holding | IJH | XBI |
|---|---|---|
| UNITED THERAPEUTICS CORP | 0.64% | 0.93% |
| NEUROCRINE BIOSCIENCES INC | 0.47% | 0.97% |
| EXELIXIS INC | 0.38% | 0.96% |
| CYTOKINETICS INC | 0.32% | 1.18% |
| ARROWHEAD PHARMACEUTICALS INC | 0.32% | 1.07% |
| BIOMARIN PHARMACEUTICAL INC | 0.30% | 0.95% |
| HALOZYME THERAPEUTICS INC | 0.26% | 1.03% |
| Only in IJH | Only in XBI |
|---|---|
| TWILIO INC 0.86% | Apogee Therapeutics Inc 1.49% |
| CARPENTER TECHNOLOGY CORP 0.85% | Moderna Inc 1.41% |
| MKS INC 0.83% | Twist Bioscience Corp 1.41% |
| CURTISS-WRIGHT CORP 0.77% | Oruka Therapeutics Inc 1.38% |
| ENTEGRIS INC 0.76% | Kymera Therapeutics Inc 1.36% |
| NVENT ELECTRIC PLC 0.76% | Viking Therapeutics Inc 1.31% |
| ATI INC 0.74% | Praxis Precision Medicines Inc 1.29% |
| ILLUMINA INC 0.73% | Erasca Inc 1.27% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
| IJH iShares Core S&P Mid-Cap ETF | XBI State Street(R) SPDR(R) S&P(R) Biotech ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | State Street |
| What it is | S&P MidCap 400 | SPDR S&P Biotech |
| Total return, 1 year | +13.4% | +64.0% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −4.1 pts | +46.5 pts |
| Expense ratio | 0.05% | 0.35% |
| Already in the S&P 500 | 0.0% | 8.5% |
| Holdings | 400 | 150 |
IJH in plain words
IJH is an index equity fund tracking the S&P MidCap 400. Over the year to Sep 11, 2026 it returned +13.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.05% a year. By its holdings filed for Jun 30, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 400 positions, with the top ten at 7.7%. It sat 5.4% below its high of Aug 14, 2026 on Sep 11, 2026.
XBI in plain words
XBI is an index equity fund tracking the SPDR S&P Biotech. Over the year to Sep 11, 2026 it returned +64.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.35% a year. By its holdings filed for Jun 30, 2026, 8% of the fund by weight is stocks the S&P 500 also holds, across 150 positions, with the top ten at 13.3%. It sat 9.6% below its high of Feb 8, 2021 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, IJH or XBI?
- In the year to Sep 12, 2026, with distributions reinvested, IJH returned +13.4% and XBI returned +64.0%, so XBI returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, IJH or XBI?
- IJH charges 0.05% a year and XBI charges 0.35%, so IJH is cheaper. Fees come from each fund's prospectus.
- How much do IJH and XBI overlap with the S&P 500?
- By their latest filed holdings, 0% of IJH and 8% of XBI by weight is stocks the S&P 500 already holds. Between the two funds, 3% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, IJH against XBI, data as of Sep 12, 2026. https://etfiq.com/compare/any/IJH-XBI Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources